ID: 73 | Pages: 140 | December 2016 | Region: North America
The North America Therapeutic Vaccines Market is set to reach $1398.88 Million by 2020 from $365.79 Million in 2015 with a CAGR of 30.77%. Therapeutics vaccines are useful tools that help in treating a disease by strengthening the patient’s immune system.
Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. With USA and Canada averaging around 300 people diagnosed per 100,000 the need for therapeutic vaccines became imminent in the region. The field of cancer immunotherapy received an important boost with the FDA’s approval of the first therapeutic cancer vaccine, which surely results in the positive growth of the market.
The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.
Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.
The North America Therapeutic Vaccines Market is segmented by the type of disease into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada. North America accounts for the large portion of revenue in the therapeutic vaccine market. The growth of this market will be boosted owing to the presence of advanced and active R&D establishments in the region.
Some of the key players influencing the North America preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Disease Type
5.1.1 Autoimmune Disease Vaccines
5.1.2 Cancer Vaccines
184.108.40.206 PR1 Peptide
5.1.3 Neurological Disease Vaccines
220.127.116.11 ACC- 001
18.104.22.168 CAD 106
22.214.171.124 Parkinson's Disease Vaccine
126.96.36.199 Alzheimer's Disease
5.1.4 Infectious Disease Vaccines
188.8.131.52 Hepatitis C
184.108.40.206 Other Infectious Disease
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 GlaxoSMithKline plc.
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Merck and Company
8.3 Bavarian Nordic
8.4 CSL Limited
8.5 Emergent Biosolutions Inc.
8.6 Novartis AG
8.7 Johnson and Johnson
8.8 MedImmune LLC
8.9 Pfizer Inc.
8.10 Sanofi Pasteur
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
|Title||Price||Add To Cart|
|Asia-Pacific Protein A Resins Market by Product Type (Natural Protein A Resin, Recombinant Protein A|
|Asia-Pacific Sleep Aids Market by Sleep Disorder (Insomnia, Sleep Apnea, Restless legs syndrome, Nar|
|Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug D|
Or follow us on social platform
© 2017 Market Data Forecast
All Rights Reserved.